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Background: The bark of magnolia has been used in Oriental medicine to treat a variety of remedies, including
some neurological disorders. Magnolol (Mag) and honokiol (Hon) are isomers of polyphenolic compounds from the
bark of Magnolia officinalis, and have been identified as major active components exhibiting anti-oxidative, anti-
inflammatory, and neuroprotective effects. In this study, we investigate the ability of these isomers to suppress
oxidative stress in neurons stimulated by the ionotropic glutamate receptor agonist N-methyl-D-aspartate (NMDA)
and oxidative and inflammatory responses in microglial cells activated by interferon-γ (IFNγ) and lipopolysaccharide
(LPS). We also attempt to elucidate the mechanism and signaling pathways involved in cytokine-induced
production of reactive oxygen species (ROS) in microglial cells.
Methods: Dihydroethidium (DHE) was used to assay superoxide production in neurons, while CM-H2DCF-DA was
used to test for ROS production in murine (BV-2) and rat (HAPI) immortalized microglial cells. NADPH oxidase
inhibitors (for example, diphenyleneiodonium (DPI), AEBSF, and apocynin) and immunocytochemistry targeting
p47phox and gp91phox were used to assess the involvement of NADPH oxidase. Western blotting was used to
assess iNOS and ERK1/2 expression, and the Griess reaction protocol was employed to determine nitric oxide (NO)
concentration.
Results: Exposure of Hon and Mag (1–10 μM) to neurons for 24 h did not alter neuronal viability, but both
compounds (10 μM) inhibited NMDA-stimulated superoxide production, a pathway known to involve NADPH
oxidase. In microglial cells, Hon and Mag inhibited IFNγ±LPS-induced iNOS expression, NO, and ROS production.
Studies with inhibitors and immunocytochemical assay further demonstrated the important role of IFNγ activating
the NADPH oxidase through the p-ERK-dependent pathway. Hon and, to a lesser extent, Mag inhibited
IFNγ-induced p-ERK1/2 and its downstream pathway for ROS and NO production.
Conclusion: This study highlights the important role of NADPH oxidase in mediating oxidative stress in neurons
and microglial cells and has unveiled the role of IFNγ in stimulating the MAPK/ERK1/2 signaling pathway for
activation of NADPH oxidase in microglial cells. Hon and Mag offer anti-oxidative or anti-inflammatory effects, at
least in part, through suppressing IFNγ-induced p-ERK1/2 and its downstream pathway.
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The bark of the magnolia tree has been used in a number
of traditional herbal medicinal preparations in Oriental
countries for thousands of years [1]. Magnolia officinalis
(China) and Magnolia obovata (Japan) contain a rich
source of biologically active compounds, including alka-
loids, coumarins, flavonoids, lignans, neolignans, and ter-
penoids [2,3]. According to in vitro and in vivo studies,
and recent clinical trials, there is strong evidence that
these constituents play an important role in the treatment
of a plethora of ailments by reducing allergic and asth-
matic reactions, and suppressing anxietic and angiogenic
responses [4-9].
Magnolol (Mag) and honokiol (Hon) (Figure 1) are poly-
phenolic compounds from Magnolia officinalis belonging
to the neolignan family. Recent evidence that these com-
pounds exert beneficial effects in neurological disorders,
such as anxiety, depression, stroke, Alzheimer’s disease,
and Parkinson’s disease, has attracted great attention and
further investigation of their molecular mechanism and
specific targets [10-15]. Neuronal excitation due to stimu-
lation by the ionotropic glutamate receptor agonists is
known to elicit a rapid influx of calcium, which triggers
downstream pathways leading to the production of reac-
tive oxygen species (ROS) and mitochondrial dysfunction
[16,17]. Understanding the underlying mechanism by which
Magnolia compounds suppress neuronal excitotoxicity may
help explain their ameliorating actions in disease models.
Studies with cell models have demonstrated anti-
inflammatory effects of Hon and Mag in mitigating
cytokine-induced nitric oxide (NO) production, expres-
sion of inducible nitric oxide synthase (iNOS), and gene-
ration of prostaglandins and leukotrienes [18-20]. This
type of inflammatory response is important in microglial
cells because their activation has been the basis of a
number of neurodegenerative diseases. Although cyto-
kines and LPS have been shown to activate microglial
cells and induce ROS and NO production, mechanistic
details within the signaling pathways leading to this type
of oxidative and inflammatory responses have not been
clearly elucidated.Honokiol
Figure 1 Structure of honokiol (Hon) and magnolol (Mag).In this study, we aim to test the ability for Hon and
Mag to suppress oxidative and inflammatory responses
in neurons and microglial cells. Studies with neurons
were based on the excitotoxic model demonstrating the
involvement of NADPH oxidase in NMDA-stimulated
ROS production [16]. Studies with microglial cells
demonstrated that NADPH oxidase was also involved in
mediating cytokine and LPS-induced ROS production.
In addition, our studies further unveiled the important
role of the IFNγ-ERK1/2 signaling pathway for ROS pro-
duction and the ability of Hon and Mag to suppress this
pathway in microglial cells.Materials and methods
Materials
Honokiol (lot number M8P0236) and magnolol (lot num-
ber M8F3374) (≥98% pure based on HPLC) were pur-
chased from Nacalai Tesque, Inc. (Kyoto, Japan). These
compounds were dissolved in dimethyl sulfoxide (DMSO)
as stock solutions. DMEM, penicillin, streptomycin, 0.05%
(w/v) trypsin/EDTA, and PBS were obtained from GIBCO
(Gaithersburg, MD). Interferon-γ (IFNγ) was purchased
from R&D Systems (Minneapolis, MN). Lipopolysaccharide
(LPS) (rough strains) from Escherichia coli F583 (Rd
mutant) and methylthiazolyldiphenyl-tetrazolium bromide
(MTT) were obtained from Sigma-Aldrich (St. Louis, MO).
The AlamarBlue™ kit was from Invitrogen (Carlsbad,
CA). Fetal bovine serum was from Atlanta Biologicals
(Lawrenceville, GA). Antibodies used for Western blotting
include: goat anti-rabbit IgG-horseradish peroxidase, goat
anti-mouse IgG-horseradish peroxidase, and iNOS poly-
clonal (Santa Cruz Biotechnology, Santa Cruz, CA); mono-
clonal anti-β-actin peroxidase (Sigma-Aldrich, St. Louis,
MO); ERK1/2, phospho-ERK1/2, (Cell Signaling, Beverly,
MA). Antibodies used for immunocytochemical staining in-
clude rabbit anti-p47phox antibodies (Calbiochem, Billerica,
MA), mouse anti-gp91phox (Thermo Fisher, Waltham,
MA), goat-anti-rabbit Alexa fluor 488 (Jackson Immunore-
search, West Grove, PA), and goat-anti-mouse Alexa fluor
549 (Jackson Immunoresearch, West Grove, PA).Magnolol
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from Invitrogen, Inc. (Carlsbad, CA), and dihydroethidium
(DHE) from Sigma-Aldrich (St. Louis, MO). Inhibitors used
in this study include: MEK inhibitor U0126 (Cell Signaling,
Beverly, MA), 4-(2-aminoethyl)-benzenesulfonylfluoride
(AEBSF, Calbiochem, San Diego, CA), diphenyleneiodo-
nium (DPI) and apocynin (Sigma-Aldrich, St. Louis, MO).
Cell culture
Preparations of primary cortical neuron cells involved
pregnant E17 Sprague–Dawley rats (Harlan, IN, USA).
All animal care and experimental protocols were carried
out in accordance with National Institutes of Health
(NIH) guidelines and with permission from the University
of Missouri Animal Care and Use Committee (protocol
#6728). Primary cortical neurons were prepared from the
cerebral cortices of E17 Sprague–Dawley rat embryos as
described [21]. Briefly, cerebral cortices were dissected
and meninges removed. The tissues were suspended in 3
ml 0.05% (w/v) trypsin/EDTA and incubated for 30 min at
37°C. The cell suspension was triturated through a fine-
burned-tip glass pipette until tissues were homogenized.
The filtrate was centrifuged at 1000g for 1 min and resus-
pended in 10% FBS in DMEM containing 100 units/ml
penicillin and streptomycin (100 μg/ml). Finally, cells were
plated in 24-well plates for MTT analysis and 35 mm
dishes for ROS detection. The plates were precoated with
poly-L-lysine (Sigma-Aldrich, St. Louis, MO) the day
before plating and incubated overnight. Four hours
after plating, culture medium was completely changed
to B27 supplemented Neurobasal medium containing
100 units/ml penicillin, 100 μg/ml streptomycin, and
glutamine. Culture was maintained by changing 1/2 volume
of B27 medium in each well every 4 days. Experiments were
conducted 8 days after plating, to ensure adequate culture
maturation.
The immortalized mouse BV-2 and rat HAPI micro-
glial cells were cultured as described previously [22].
Briefly, cells were cultured in 75 cm2 flasks with DMEM
(high glucose) supplemented with 10% FBS containing
100 units/ml penicillin and 100 μg/ml streptomycin, and
maintained in a 5% CO2 incubator at 37°C. For subcul-
ture, cells were removed from the culture flask with a
scraper, resuspended in the culture medium and subcul-
tured in 12, 24, or 96-well plates for experiments.
Assessing cell viability
Two assay protocols were used to assess neuron viability
after exposure to Hon and Mag. Since mitochondrial
dysfunction is an initial step in apoptotic pathways that
lead to neuronal cell death, the MTT assay was used to
determine mitochondrial dysfunction. In this assay, neu-
rons were cultured in 24-well plates and treated with
Hon or Mag (1 to 10 μM) at 37°C for 24 h. Aftertreatment, culture medium was removed and 1 ml of
MTT reagent (0.5 mg/ml) dissolved in serum-free
DMEM was added to each well. The plates were incu-
bated for 3 h at 37°C, and the formazan particles in each
well were dissolved in 500 μl of DMSO. After shaking
the plates at room temperature for 5 min, absorbance
was read at 540 nm using a Synergy4 Plate Reader (Bio-
Tek Instruments, Inc., Fisher Scientific, St. Louis, MO,
USA.).
AlamarBlue™ is a cell-permeable nonfluorescent dye,
which can be converted into red fluorescence on reduc-
tive reactions within live cells. This assay was used to
determine the extent of neuronal viability after exposure
to Hon and Mag (1 to 10 μM). In this assay, neurons
were cultured in 24-well plates and then treated with
Hon or Mag (1 to 10 μM) at 37°C for 24 h. After treat-
ments, 100 μl of AlamarBlueTM was added to each well
and neurons were further incubated at 37°C for 3 h. Ab-
sorbance was read at 570 nm using the Synergy4 Plate
Reader (BioTek) with measurement at 600 nm as a
reference.
Measurement of superoxide in neurons and ROS
production in microglial cells
Dihydroethidium (DHE) is oxidized by superoxide
anions to produce fluorescent ethidium, which is inter-
calated into DNA, and can be quantified by summing
the fluorescence within the cell [23]. This protocol has
been successfully used to measure superoxide produc-
tion in neurons [16,21]. Neurons were cultured on 35
mm dishes precoated with poly-L-lysine. Neurons were
then treated with Hon or Mag (10 μM) for 30 min, and
exposed to NMDA (100 μM) for 30 min in phenol red
free Neurobasal medium with 0.5 mg/ml BSA. At 30
min prior to image acquisition, cells were loaded with
DHE (10 μM) and incubated at 37°C. Fluorescence
images were acquired using a Nikon TE-2000 U inverted
microscope with a 20× NA 0.95 objective and a cooled
charge-coupled device (CCD) camera controlled with a
computer running MetaView imaging software (Univer-
sal Imaging, West Chester, PA). The fluorescence excita-
tion source was controlled with a Uni-Blitz mechanical
shutter. For image acquisition, a short exposure time
(200 ms) and low-intensity excitation light were applied
to minimize photobleaching. Digital images were ana-
lyzed using the MetaView software with automatic back-
ground subtraction. Threshold fluorescence levels were
obtained for each image prior to the quantification. For
each field, the total fluorescence was measured and
expressed as the average fluorescence normalized by the
total number of cells. For each treatment group, at least
three random images from the same dish were captured
and analyzed, and each treatment was repeated three
times independently for statistical analysis.
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cells, we adopted a protocol using CM-H2DCF-DA, a
compound that becomes fluorescent upon interacting
with ROS including H2O2 [24]. In this study, microglial
cells were seeded in 96-well plates, and when they be-
came 90% confluent, they were serum-starved for 4 h.
Cells were treated with cytokines or LPS, or both, for
different times and CM-H2DCF-DA (10 μM) was added
1 h before measurement. In some experiments, cells
were pretreated with U0126 or Hon or Mag for 1 h prior
to stimulating with IFNγ for 11 h, the CM-H2DCF-DA
(10 μM) was then added and the cells were further incu-
bated for 1 h. The fluorescent intensity of DCF was mea-
sured using the Synergy4 microplate reader with an
excitation wavelength of 490 nm and an emission wave-
length of 520 nm.
Measurement of NO
Cells were serum-starved in phenol red free DMEM for
3 h, followed by pretreatment of compounds of interest
for 1 h. Cells were then treated with IFNγ and LPS or
IFNγ alone and incubated at 37°C for 16 h. Nitric oxide
released from cells was converted to nitrite in the cul-
ture medium, which was determined using the Griess re-
agent protocol. Aliquots (50 μl) of culture medium were
transferred to a 96-well plate and incubated with 50 μl
of Reagent A (1% sulfanilamide in 5% phosphoric acid)
per well for 10 min at room temperature, covered and in
the dark. This was followed by incubation with 50 μl of
reagent B (0.1%, w/v, N-1-napthylethylenediamine dihy-
drochloride, Sigma-Aldrich) per well for 10 min at room
temperature, covered and in the dark. Serial dilutions of
sodium nitrite (0 to 100 μM) were used to generate the
nitrite standard reference curve. Following the incuba-
tion period, absorbance at 543 nm was measured using
the Synergy4 microplate reader.
Western blot analysis
Cells were harvested in lysis radioimmunoprecipitation
assay (RIPA) buffer containing 50 mM Tris–HCl (pH
7.5), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, and 0.1% sodium dodecyl sulfate (SDS).
The extract was centrifuged at 10,000g for 15 min at 4°C
to remove cell debris. Protein concentration was deter-
mined with the BCA protein assay kit (Pierce Biotech-
nology, Rockford, IL). For each sample, 5 μg of protein
was loaded and resolved in 8% SDS-PAGE and run at
100 V. After electrophoresis, proteins were transferred
to 0.45 μm nitrocellulose membranes at 300 mA for 3 h.
Membranes were blocked in Tris-buffered saline (TBS),
pH 7.4, with 0.1% Tween 20 (TBS-T) containing 5%
nonfat milk for 1 h at room temperature. For different
experiments, the blots were incubated with ERK1/2
(1:2000), phospho-ERK1/2 (1:2000), iNOS polyclonal(1:1000) antibodies overnight at 4°C. After repeated wash-
ing with TBS-T, blots were incubated with goat anti-rabbit
IgG- horseradish peroxidase (1:4000) or goat anti-mouse
IgG- horseradish peroxidase (1:2000) for 1 h at room
temperature. The blots were then washed three times with
TBS-T. Immunolabeling was detected by chemilumines-
cence ECL/WestPico/femto. For loading control, blots
were incubated with monoclonal anti-β-actin peroxidase
(1:30,000). For quantification, blots were scanned and the
intensity of protein bands was measured as optical density
using the QuantityOne program (BioRad, Hercules, CA).
Immunostaining of p47phox and gp91phox in microglial
cells
BV-2 microglia cells were serum-starved for 4 h, followed
by stimulation with IFNγ (10 ng/ml) for 12 h. The cells
were fixed in 4% paraformaldehyde for 15 min and then
permeabilized with 0.1 % Triton X-100 in PBS for 30 min.
Cells were incubated with 10% normal goat serum in
0.005% Triton X-100 in PBS for 60 min. Cells were then
incubated overnight in 0.5% normal goat serum in 0.005%
Triton X-100 in PBS containing primary antibodies: rabbit
anti-p47phox antibodies (1:500; Calbiochem) and mouse
anti-gp91phox antibodies (1:500; Thermo Fisher). The
next day, cells were incubated in 0.005% Triton X-100 in
PBS containing secondary antibodies, goat-anti-rabbit
Alexa fluor 488 (Jackson Immunoresearch) and goat-anti-
mouse Alexa fluor 549 (Jackson Immunoresearch) for 60
min, followed by nuclear counterstaining in PBS con-
taining 1 μg/ml of 4,6-diamidine-2-phenylindole dihy-
drochloride (Pierce) for 10 min. The coverslips were then
mounted on fluoromount (Sigma-Aldrich) and sealed with
nail polish. Fluorescence photomicrographs were captured
using a Leica DMI 6000B fully automated epifluorescence
microscope (Leica Microsystems Inc., Buffalo Grove, IL)
as serial z-stack images and processed for deconvolution
with AF6000 applications.
Statistical analysis
Data are presented as mean ± standard error of the mean
(SEM). Results were analyzed by one-way analysis of va-
riance (ANOVA) followed by Dunnett’s multiple compari-
son tests or two-way ANOVA with Bonferroni posttests
(V4.00; GraphPad Prism Software Inc., San Diego, CA).
Statistical significance was considered for P < 0.05.
Results
Hon and Mag suppressed NMDA-induced superoxide
production in neurons
Since our earlier study had demonstrated the involvement
of NADPH oxidase in the production of superoxide on
stimulating neurons with the ionotropic glutamate recep-
tor agonist, NMDA [16], this protocol was used to exa-
mine the ability of Hon and Mag to suppress neuronal
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used to mark mitochondrial dysfunction and the Alamar-
Blue™ assay was used to assess neuron cell death. As
shown in Figure 2A, treatment of neurons with Hon and
Mag (1 to 10 μM) for 24 h neither alters mitochondrial
function nor causes neuron cell death.
Subsequently, we tested the effects of Hon and Mag
on superoxide production in neurons stimulated with
NMDA (100 μM for 30 min). Treatment of neurons with
NMDA elicited a large increase in superoxide produc-
tion (Figure 2B, C). Hon and Mag (10 μM) alone did not
elicit superoxide production in neurons; however, both
compounds significantly inhibited NMDA-induced super-
oxide production (Figure 2B, C).
Hon and Mag inhibited IFNγ- and LPS-induced iNOS
expression and NO production in BV-2 microglial cells
As with our previous study [25], treatment of BV-2
microglial cells with IFNγ + LPS caused the induction of
iNOS expression and a correlative increase in NO pro-
duction (Figure 3). Hon and, to a lesser extent, Mag
inhibited LPS+IFNγ-induced iNOS expression and NO
production in BV-2 cells in a dose-dependent manner
(Figure 3). Significant inhibition of NO (P < 0.05) by
Hon was observed at 1 μM, whereas significant inhi-
bition for Mag was observed at 6 μM. Western blot ana-
lysis also indicated a dose-dependent inhibition of iNOS
protein expression by Hon and Mag (Figure 3B, C).
Similar to results observed by our earlier study [25],
addition of IFNγ to BV-2 microglial cells greatly stimu-
lated LPS-induced iNOS expression and NO production.
Under this condition, Hon and, to a lesser extent, Mag
could dose-dependently inhibit the induction of iNOS
and NO induced by IFNγ (Figure 4A-C). In fact, inhib-
ition of IFNγ-induced NO production was similar to that
using LPS + IFNγ (Figure 3A).
To confirm the effects of Hon and Mag on IFNγ-induced
NO production in other types of microglial cells, rat HAPI
microglial cells were tested. As shown in Figure 5A, similar
results were obtained for Hon to inhibit IFNγ-induced NO
in HAPI cells. On the other hand, Mag appeared to provide
greater inhibition in HAPI cells as compared to BV-2 cells
(Figure 5B).
ROS production in BV-2 microglial cells
Although previous studies have demonstrated the ability
for LPS + IFNγ to induce ROS production in microglial
cells, little is known about the source and the mechanism
of action of the cytokines. In this study, a time course ex-
periment was carried out to examine ROS production on
treating BV-2 microglial cells to LPS or IFNγ. Data in
Figure 6A showed no detectable ROS during the initial 4 h
after exposing cells to LPS or IFNγ. Lipopolysaccharide
alone showed a slow increase in ROS after 4 h and peakedat 16 h, whereas IFNγ induced about 50% more ROS than
LPS. When cells were treated with IFNγ together with LPS,
there was a left shift for ROS production although the peak
level was similar to that induced by IFNγ alone (Figure 6A).
Based on the time course conditions, we used the 12 h
time point to examine whether Hon and Mag may alter
IFNγ-induced ROS production. Results indicated that
Hon and, less effectively, Mag did inhibit IFNγ-induced
ROS production in a dose-dependent manner. However,
neither compound alone could exert obvious effects on
the basal ROS production (Figure 6B, C).
NADPH oxidase is involved in IFNγ-induced ROS
production
We further investigated whether NADPH oxidase might
be the target enzyme for the ROS induced by IFNγ in
microglial cells by testing with inhibitors commonly
used for NADPH oxidase. Results show that DPI, a non-
specific oxidase inhibitor, and AEBSF, a serine protease
inhibitor [26], could inhibit IFNγ-induced ROS in micro-
glial cells in a dose-dependent manner (Figure 7A, B).
Using these inhibitors, we further tested whether IFNγ-
induced ROS is critical for downstream signaling pathway
leading to NO production. As shown in Figure 7C and D,
DPI and AEBSF similarly inhibited IFNγ-induced NO pro-
duction. Apocynin, a botanical compound known to
inhibit translocation of cytosolic subunits p47phox and
p67phox to the membrane complex [27], was shown to
inhibit IFNγ-induced NO production albeit at high con-
centrations, starting at 40 μM (Figure 7E).
Activation of NADPH oxidase is known to act through a
complex mechanism involving activation of cytosolic sub-
units (p47phox, p67phox, p40phox, Rac) to dock with the
membrane subunits (gp91phox, p22phox). In the past, sev-
eral types of kinase have been shown to phosphorylate the
cytosolic subunits (p47phox, p67phox, p40phox) [28]. In
this study, double immunocytochemical staining was used
to demonstrate that IFNγ could induce the translocation
of p47phox from the cytosol to dock with the gp91phox in
the membrane (Figure 8), further supporting the involve-
ment of the NADPH oxidase in the ROS production.
IFNγ-induced phosphorylation of MAPK/ERK1/2
Although cytokines and LPS were shown to induce phos-
phorylation of ERK1/2, it is not clear whether this
response is a reflection of IFNγ [25]. Therefore, a time
course assay was carried out to examine the ability of IFNγ
to induce p-ERK1/2. IFNγ induced a steady increase in
p-ERK1/2 expression, which was noticeable around 1 h
and reached a plateau after 4 h (Figure 9A-C). Hon and, to
a lesser extent, Mag inhibited IFNγ-induced ERK1/2 phos-
phorylation in a dose-dependent manner (Figure 10A-C).
Similarly, Hon also inhibited IFNγ-induced pERK1/2 in
HAPI cells (Figure 11A-C).
Figure 2 Hon and Mag do not alter cell viability and inhibit NMDA-induced ROS production in primary rat cortical neurons. (A)
Exposure of Hon and Mag (1 to 10 μM) to primary cortical neurons for 24 h did not alter neuronal viability as assayed by MTT and AlamarBlue.
(B) Representative bright field and DHE fluorescence photomicrographs depicting ROS production in primary neurons after cells were treated with
Hon or Mag (10 μM) for 30 min prior to stimulation with NMDA (100 μM) for 30 min. For ROS production, neurons were loaded with dihydroethidium
(DHE, 10 μM) 30 min prior to image acquisition under different treatment conditions. Procedure for fluorescence determination is described in text.
(C) Bar graph of average fluorescence depicting significant inhibition of NMDA-induced ROS production by Hon and Mag. Data are expressed as the
mean ± SEM from three individual experiments and analyzed by two-way ANOVA with Bonferroni posttests. ** denote significant difference between
control and NMDA (P < 0.001), ## indicate significant decrease in ROS production by Hon and Mag as compared to NMDA (P < 0.01).
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and NO production
To test whether IFNγ-induced p-ERK1/2 is upstream of
ROS and NO production, the MEK1/2 inhibitor, U0126,
was used to block phosphorylation of ERK1/2 by MEK1/2.As shown in Figure 12A, U0126 effectively inhibited IFNγ-
induced p-ERK1/2 in BV-2 cells. U0126 also inhibited
IFNγ-induced ROS production in a dose-dependent man-
ner, whereas U0126 did not influence basal ROS produc-
tion in BV-2 cells (Figure 12B). Under similar conditions,
Figure 3 Hon and Mag inhibit LPS + IFNγ-induced NO production and iNOS expression in BV-2 microglial cells. Cells were treated with
Hon or Mag (1 to 10 μM) for 1 h followed by stimulation with LPS (100 ng/ml) + IFNγ (10 ng/ml) for 16 h. (A) Culture media were collected for
determination of NO using the Griess reaction protocol as described in text. (B) Representative Western blots of iNOS protein and β-actin. (C) Bar
graphs representing iNOS/β-actin ratios. Results were expressed as the mean ± SEM (n = 3) and significant difference from the respective LPS + IFNγ
stimulated group was determined by one-way ANOVA followed by Dunnett’s tests, ** P < 0.01; ***P < 0.001.
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in BV-2 and HAPI cells (Figure 12C).
Discussion
In this study, we used rat primary cortical neurons and
immortalized microglial cells (murine BV-2 and rat HAPI)
to demonstrate the ability of Hon and Mag to suppress
oxidative and inflammatory responses induced by NMDA
in neurons and IFNγ ± LPS in microglial cells. Exposure
of neurons to Hon and Mag (up to 10 μM) for 24 h did
not alter neuronal viability, but both compounds (10 μM)
dramatically inhibited NMDA-induced superoxide pro-
duction. Results from earlier studies have demonstrated
involvement of NADPH oxidase in neuronal excitation
[16,17], and Mag and Hon were shown to offer protection
against neuronal toxicity induced by hydrogen peroxide
and ionotropic glutamate receptor agonist [29]. These and
other results are in line with the suggestion of possible
therapeutic application of these compounds to treat
neurological disorders [1].
The induction of iNOS expression and NO production
by pro-inflammatory cytokines and LPS is known to in-
volve the transcriptional pathways associated with NF-κBand the canonical JAK/STAT pathway induced by IFNγ
[22,30]. Interestingly, in BV-2 and HAPI microglial cells,
LPS and IFNγ can individually stimulate iNOS/NO pro-
duction, suggesting presence of cross-talk mechanisms
between these two pathways [25,31,32]. There is evidence
that signaling molecules, such as protein kinase C and
mitogen-activated protein kinase (MAPK), can mediate
the cross-talk pathways [22,33]. In studies with microglial
cells, increase in MAPK-ERK1/2 activity has been shown
to occur during induction of iNOS by LPS and IFNγ
[34-36]. Our results here also demonstrated the ability for
IFNγ alone to stimulate phosphorylation of ERK1/2 in
microglial cells (Figure 9A, B). However, unlike studies in
which neurons show a rapid induction of p-ERK1/2 in
minutes in response to NMDA stimulation [16], phos-
phorylation of ERK1/2 by IFNγ in BV-2 microglial cells
turned out to be a much slower and gradual process, first
observable after 1 h and reaching a plateau around 4 h. In
human macrophages, stimulation of p-ERK1/2 by IFNγ
exhibited an even longer delay time, of 6 h [37]. Appa-
rently, the time required for ERK1/2 phosphorylation va-
ries depending on the cell types and agonists used for
activation [38].
Figure 4 Hon and Mag inhibit IFNγ-induced NO production and iNOS expression in BV-2 microglial cells. Cells were treated with Hon or
Mag (1 to 10 μM) for 1 h followed by stimulation with IFNγ (10 ng/ml) for 16 h. (A) Culture media were collected for determination of NO using the
Griess reaction protocol as described in text. (B) Representative Western blots of iNOS protein and β-actin. (C) Bar graphs representing iNOS/β-actin
ratios. Results were expressed as the mean ± SEM (n = 3) and significant difference from the respective IFNγ stimulated group was determined by
one-way ANOVA followed by Dunnett’s tests, *P < 0.05, **P < 0.01, ***P < 0.001.
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to stimulate ROS production in microglial cells, the
mechanisms for ROS production have not been clearly
elucidated [39]. In our study with microglial cells, ROS
production induced by LPS and IFNγ was not observed
before 4 h (Figure 6A). Since IFNγ-induced ROS pro-
duction was inhibited by the MEK inhibitor (U0126,
Figure 12B), it is reasonable to conclude that p-ERK1/2
plays an important role in the induction process. Our
results support earlier studies demonstrating the involve-
ment of ERK1/2 from IFNγ to stimulate superoxide in a
mixed glial cell culture [36]. Our study further provided
evidence for involvement of NADPH oxidase in IFNγ-
induced ROS production in microglial cells. Inhibitors,
such as DPI and AEBSF, not only inhibited ROS but
also NO production, suggesting that ROS production
precedes induction of iNOS. To demonstrate further the
involvement of NADPH oxidase in IFNγ-induced ROS
production, double immunocytochemical staining showed
translocation of p47phox from cytoplasm to membraneand co-localized with the gp91phox after treating cells with
IFNγ (Figure 8). In a study with macrophages, IFNγ was
shown to activate NADPH oxidase through increase in
intracellular trafficking and expression of gp91phox [40].
Many extracellular signals are coupled with cell sur-
face receptors linking to activation of the MAPK path-
way. In this study, we demonstrated the role of IFNγ in
stimulating ROS from NADPH oxidase through the
MEK-ERK1/2 pathway. Indeed, activation of ERK1/2 has
been shown to elicit multiple downstream events, in-
cluding phosphorylation of cytosolic phospholipase A2
(cPLA2) and arachidonic acid release in neurons [16], pro-
duction of filopodia in BV-2 microglial cells [25], transcy-
tosis of macromolecules across the epithelial monolayers
[37], and enhanced phosphorylation of STAT1 [41].
Taken together, these results demonstrated a novel role
of IFNγ in stimulating the MAPK-ERK1/2 pathway, and
in turn, in activating ROS production through NADPH
oxidase. Since IFNγ-induced p-ERK is upstream of ROS
and iNOS/NO production, agents that inhibit p-ERK1/2
Figure 5 Hon and Mag inhibit IFNγ-induced NO production in HAPI microglial cells. Cells were treated with (A) Hon or (B) Mag (1 to 10 μM)
for 1 h followed by stimulation with IFNγ (10 ng/ml) for 16 h. Culture media were collected for determination of NO using the Griess reaction protocol
as described in text. Results were expressed as the mean ± SEM (n = 3) and significant difference from the respective IFNγ-stimulated group was
determined by one-way ANOVA followed by Dunnett’s tests, *P < 0.05, **P < 0.01, ***P < 0.001.
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Understanding this mechanism helps to explain earlier
observations that LPS + IFNγ induced ROS production in
microglial cells preceded the induction of iNOS [42].
Many natural polyphenols, including luteolin, gastrodin,
and ginsenoside, exhibit anti-inflammatory properties and
inhibit LPS/IFNγ-induced NO production in microglial
cells, either through ERK1/2 or other types of MAPK
[7,43-47]. Other studies have demonstrated the ability of
Hon and Mag to inhibit cytokine-induced NO productionFigure 6 Hon and Mag inhibit cytokine-induced ROS production in BV
LPS or IFNγ. Cells were treated with LPS (100 ng/ml) or IFNγ (10 ng/ml) for th
described in the text. Similarly, (B) Hon and (C) Mag (1 to 10 μM) were given
as the mean ± SEM (n = 3) and significant difference from the respective IFNγ
Dunnett’s tests, *P < 0.05; ** P < 0.01.and expression of iNOS, as well as generation of pros-
taglandins and leukotrienes [18-20,48]. Our studies un-
veiled the role of the IFNγ-ERK1/2 pathway in ROS pro-
duction through NADPH oxidase, and the ability of Hon
and Mag to suppress this oxidative and inflammatory
responses in microglial cells. Understanding this mechan-
ism can help to explain the ability of these botanicals to
suppress hyperactivity in brain and retard microglial cell
activation and ameliorate neuroinflammatory responses
associated with neurodegenerative diseases.-2 microglial cells. (A) Time course for ROS production induced by
e time indicated. ROS production was measured using CM-H2DCFDA as
1 h prior to exposure to IFNγ (10 ng/ml) for 12 h. Results are expressed
-stimulated group was determined by one-way ANOVA followed by
Figure 7 Activation of NADPH oxidase and ROS production is upstream of NO production in BV-2 microglial cells. Cells were pretreated
with (A) DPI (0.1 to 1.0 μM) or (B) AEBSF (6.25 to 200 μM) for 1 h prior to exposure to IFNγ (10 ng/ml) for 12 h, followed by measurement of ROS
with CM-H2DCFDA as described in text. Cells were pretreated with (C) DPI (0.05 to 0.2 μM), (D) AEBSF (12.5 to 100 μM), or (E) apocynin (50 to
400 μM) for 1 h prior to exposure to IFNγ (10 ng/ml) for 16 h, followed by measure of nitrite with Griess reaction protocol as described in the
text. Results are expressed as the mean ± SEM (n = 3), and significant difference from the respective IFNγ-stimulated group was determined by
one-way ANOVA followed by Dunnett’s tests, *P < 0.05; **P < 0.01.
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In summary, our studies with neurons and microglial
cells provided strong evidence for anti-oxidative and
anti-inflammatory effects of Hon and Mag and under-
score the important role of NADPH oxidase in the
superoxide/ROS production in these cells. ResultsFigure 8 Involvement of NADPH oxidase in IFNγ-induced NO product
for 12 h. Immunocytochemistry was performed with antibodies against p47
fluorescence microscope as serial z-stack images, followed by deconvolutiowith microglial cells further unveiled the important
role of IFNγ in stimulating signaling pathways involv-
ing activation of ERK1/2, ROS, and NO. These results
also provide a useful and novel platform for testing
anti-oxidative and anti-inflammatory effects of other
botanicals.ion in BV-2 microglial cells. Cells were exposed to IFNγ (10 ng/ml)
phox (green) and gp91phox (red). Images were taken under
n processing.
Figure 10 Hon and Mag inhibit IFNγ-induced activation of p-ERK1/2 in BV-2 microglial cells. (A) Western blot analysis showing a
representative experiment of Hon or Mag pretreatment on IFNγ to induce p-ERK1/2 phosphorylation in BV-2 microglia cells. Cells were treated
with either Hon or Mag (1 to 10 μM) for 1 h followed by stimulation with IFNγ (10 ng/ml) for 4 h. (B & C) Results of protein band intensities are
expressed as arbitrary units of phospho-ERK1/2 against total ERK1/2. Results are expressed as the mean ± SEM (n = 3) and significant difference
from the respective IFNγ stimulated group was determined by one-way ANOVA followed by Dunnett’s tests, *P < 0.05; ** P < 0.01; *** P < 0.001.
Figure 9 Time course of IFNγ-induced activation of p-ERK1/2 in BV-2 microglial cells. (A) Western blot analysis of a typical time course for
IFNγ (10 ng/ml) to induce ERK1/2 phosphorylation in BV-2 microglia cells. Cell lysates were extracted at the time indicated. (B, C) Results of
protein band intensities are expressed as arbitrary units of phospho-ERK1/2 against total ERK1/2 for (B) ERK1 and (C) ERK2. Results are expressed
as mean ± SEM (n = 3).
Chuang et al. Journal of Neuroinflammation 2013, 10:15 Page 11 of 14
http://www.jneuroinflammation.com/content/10/1/15
Figure 12 Role of ERK1/2 activation in IFNγ-induced ROS and NO production in BV-2 and HAPI microglial cells. Cells were treated with
IFNγ (10 ng/ml) with or without the MEK1/2 inhibitor, U0126 (1.25 to 10 μM). (A) Representative Western blot demonstrated ability for U0126 to
inhibit phosphorylation of ERK1/2 dose-dependently 4 h after IFNγ treatment. (B) For ROS production, BV-2 cells were pretreated with different
concentrations of U0126 for 1 h prior to stimulation with IFNγ for 12 h. (C) For NO production, both BV-2 and HAPI cells were pretreated with
different concentrations of U0126 for 1 h prior to stimulation with IFNγ for 16 h. Results are expressed as the mean ± SEM (n = 3), and significant
difference from the respective IFNγ stimulated group was determined by one-way ANOVA followed by Dunnett’s tests, ** P < 0.01; *** P < 0.001.
Figure 11 Hon inhibits IFNγ-induced activation of p-ERK1/2 in HAPI microglial cells. (A) Western blot analysis showing a representative
experiment of Hon pretreatment on IFNγ to induce ERK1/2 phosphorylation in HAPI microglial cells. Cells were treated with Hon (1 to 10 μM) for 1 h
followed by stimulation with IFNγ (10 ng/ml) for 4 h. (B & C) Results of protein band intensities are expressed as arbitrary units of phospho-ERK1/2
against total ERK1/2. Results are expressed as the mean ± SEM (n = 3) and significant difference from the respective IFNγ stimulated group was
determined by one-way ANOVA followed by Dunnett’s tests, *P < 0.05; ** P < 0.01; *** P < 0.001.
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